Kimberly Chong

Array ( [id] => 6201918 [patent_doc_number] => 20110064704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'SHIP-DEFICIENCY TO INCREASE MEGAKARYOCYTE AND PLATELET PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/883470 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9760 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064704.pdf [firstpage_image] =>[orig_patent_app_number] => 12883470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8630161 [patent_doc_number] => 08362232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Compounds and methods for modulating expression of SGLT2' [patent_app_type] => utility [patent_app_number] => 12/883049 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137585 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12883049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030935 [patent_doc_number] => 20110081337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'FUNCTION OF GPR4 IN VASCULAR INFLAMMATORY RESPONSE TO ACIDOSIS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/882187 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7331 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081337.pdf [firstpage_image] =>[orig_patent_app_number] => 12882187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026328 [patent_doc_number] => 20110079528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING DISEASE INCLUDING INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/881562 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19274 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20110079528.pdf [firstpage_image] =>[orig_patent_app_number] => 12881562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074394 [patent_doc_number] => 08551971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Composition for treatment of pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 13/499005 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4378 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882495 [patent_doc_number] => 08906873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Modulation of huntingtin expression' [patent_app_type] => utility [patent_app_number] => 13/395188 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 42236 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174542 [patent_doc_number] => 20110177131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'siRNA SILENCING OF FILOVIRUS GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/878946 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28514 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177131.pdf [firstpage_image] =>[orig_patent_app_number] => 12878946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762812 [patent_doc_number] => 08114984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'RNAi modulation of Aha and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/877025 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32340 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114984.pdf [firstpage_image] =>[orig_patent_app_number] => 12877025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953157 [patent_doc_number] => 20110033859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'RNAi INHIBITION OF INFLUENZA VIRUS REPLICATION' [patent_app_type] => utility [patent_app_number] => 12/875695 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 72804 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033859.pdf [firstpage_image] =>[orig_patent_app_number] => 12875695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241025 [patent_doc_number] => 20120149760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'DISABLING AUTOPHAGY AS A TREATMENT FOR LYSOSOMAL STORAGE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/391265 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34402 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228402 [patent_doc_number] => 20120142610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'TREATMENT OF \'IQ MOTIF CONTAINING GTPASE ACTIVATING PROTEIN\' (IQGAP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IQGAP' [patent_app_type] => utility [patent_app_number] => 13/388817 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25168 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632175 [patent_doc_number] => 20100311824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'MODULATION OF FORKHEAD BOX O1A EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/860137 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37708 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311824.pdf [firstpage_image] =>[orig_patent_app_number] => 12860137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4550446 [patent_doc_number] => 07960541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Antisense oligonucleotides for inducing exon skipping and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/860078 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20337 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960541.pdf [firstpage_image] =>[orig_patent_app_number] => 12860078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359708 [patent_doc_number] => 20120214864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'MIRNAS DYSREGULATED IN TRIPLE-NEGATIVE BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/390460 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 30708 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922892 [patent_doc_number] => 08980854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'miRNA compounds for treatment of prostate carcinoma' [patent_app_type] => utility [patent_app_number] => 13/390028 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31573 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619274 [patent_doc_number] => 20100324121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA' [patent_app_type] => utility [patent_app_number] => 12/855223 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13046 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324121.pdf [firstpage_image] =>[orig_patent_app_number] => 12855223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632156 [patent_doc_number] => 20100311823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'AGENT FOR REGULATING BONE FORMATION' [patent_app_type] => utility [patent_app_number] => 12/855242 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9007 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311823.pdf [firstpage_image] =>[orig_patent_app_number] => 12855242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388972 [patent_doc_number] => 20100317719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field' [patent_app_type] => utility [patent_app_number] => 12/854558 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12922 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317719.pdf [firstpage_image] =>[orig_patent_app_number] => 12854558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137088 [patent_doc_number] => 20110009472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'RNAi Probes Targeting Cancer-Related Proteins' [patent_app_type] => utility [patent_app_number] => 12/845521 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7662 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009472.pdf [firstpage_image] =>[orig_patent_app_number] => 12845521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394284 [patent_doc_number] => 20120232124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR PROGNOSIS AND TREATMENT OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 13/390995 [patent_app_country] => US [patent_app_date] => 2010-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19116 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390995 [rel_patent_id] =>[rel_patent_doc_number] =>)